BioSimilar

MedPAC Proposes Changes to Medicare Part D for Biosimilars

Read more

FDA Approves Sixth United States Biosimilar

Read more

Biotechnology Investors Beware?

Read more

FDA Finalizes Guidance on Assigning Non-Proprietary Names to Biologics and Biosimilars

Read more

2017 Biosimilar Update

Read more

FDA Extends Wait for Biosimilar Interchangeability Guidance

Read more

FDA Releases Draft Guidance for Industry on Biosimilar Interchangeability

Read more

The Uncertain Future of Biosimilars in the United States

Read more

Alliance for Health Reform Holds Biosimilar Panel

Read more

FDA Announces Information Collection Regarding Biosimilar Suffixes

Read more